Notice of Intent - Digital Pathology Platform Enterprise Software Licenses

PRESOLICITATION NOTICE OF INTENT

NON-COMPETITIVE

INTRODUCTION

PURSUANT TO FAR Subpart 5.2—Synopses of Proposed Contract Actions, THIS IS A PRE-SOLICITATION NOTICE OF A PROPOSED CONTRACT ACTION.   

THIS IS A PRE-SOLICITATION NON-COMPETITIVE NOTICE OF INTENT TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). 

The National Institute on Drug Abuse (NIDA), NIDA Office of Acquisition – NCATS Section, on behalf of the National Center for Advancing Translational Sciences (NCATS), intends to negotiate and award a purchase order without providing for full and open competition (including brand-name) to:

Indica Labs, Inc.

2469 Corrales Rd. Bldg A-3

Corrales, NM 87048

for renewal of enterprise licenses for HALO digital pathology software.

NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE

The intended procurement is classified under NAICS code 513210 Software Publishers with a size standard of $47 million.

REGULATORY AUTHORITY

The resulting contract will include all applicable provisions and clauses of the Federal acquisition Requlation (FAR) in effect through Federal Acquisition Circular (FAC) 2024-05 (5/22/2024).

STATUTORY AUTHORITY

This acquisition is conducted as non-competitive under the authority of 41 U.S.C. 3304(a)(1) and FAR 6.302-1, Only one responsible source ad no other supplies or services will satisfy agency requirements.

DESCRIPTION OF REQUIREMENT

Purchase Description

HALO Digital Pathology Enterprise Software License Renewal

Purpose and Objectives

This requirement is to renew enterprise licenses for the installed base of HALO digital pathology software tools. This software provides for specialized analysis and management of digital pathology images.

The HALO platform is hosted by NCATS and made available to multiple users of the NCATS Secure Scientific Platforms Environment (the “Environment”), an NCATS-hosted platform for collaboration across NIH institutes and centers, other Government agencies, and external collaborators. HALO receives particularly intensive use by users from the National Cancer Institute (NCI), NCATS, and the National COVID Cohort Collaborative (N3C).

The acquisition consists of renewal of the enterprise licenses for the following commercial items:

Please see Atachment.

The salient characteristic of this requirement is the vendor’s ability to provide renewal of the  enterprise-wide license for this software.

HALO software is licensed exclusively through Indica Labs, Inc., and is not sold through resellers.

Period of Performance

The license period is Ten (10) Months.

The award is expected to include two one-year option periods.

Option Period One (1): 12 Months

Option period Two (2): 12 Months

CLOSING STATEMENT

This synopsis is not a request for competitive proposals.  However, all responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency.

Responses to this notice must include sufficient information to establish the interested parties’ bona-fide capabilities of providing the product or service.  The price quote shall include: unit price, list price, shipping and handling costs, delivery days after contract award, delivery terms, prompt payment discount terms, F.O.B. Point (Destination or Origin), product or catalog number(s); product description; and any other information or factors that may be considered in the award decision.  Such factors may include: past performance; special features required for effective program performance; trade-in considerations; probable life of the item selected as compared with that of a comparable item; warranty considerations; maintenance availability; and environmental and energy efficiency considerations.

Respondents that believe that they are manufacturers or authorized resellers of the brand-name product specified in this announcement must provide, as part of their response: (a) product, catalog, model, and/or part number(s); (b) product description; (c) all relevant information and documentation that the item(s) offered meets the salient physical, functional, or performance characteristics as specified in the purchase description; quantity; estimated price or cost; shipping, handling, and/or installation charges; and delivery date after receipt of order. 

In addition the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size must be included in the response. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.

A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government.  The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement.  

All responses must be received by 9:00 a.m. Eastern time on September 3, 2024, and reference notice no. 75N95024Q00118. Responses must be submitted by email to Nick Niefeld, Contract Specialist, nick.niefeld@nih.gov.